Abstract
Three enzyme activities in the protozoan Leishmania major, namely N5,N10-methylenetetrahydrofolate dehydrogenase/N5,N10-methenyltetrahydrofolate cyclohydrolase (DHCH) and N10-formyltetrahydrofolate ligase (FTL) produce the essential intermediate N10-formyltetrahydrofolate. Although trypanosomatids possess at least one functional DHCH, the same is not true for FTL, which is absent in Trypanosoma brucei. Here, we present the 2.7 Å resolution crystal structure of the bifunctional apo-DHCH from L. major, which is a potential drug target. Sequence alignments show that the cytosolic enzymes found in trypanosomatids share a high level of identity of approximately 60%. Additionally, residues that interact and participate in catalysis in the human homologue are conserved amongst trypanosomatid sequences and this may complicate attempts to derive potent, parasite specific DHCH inhibitors.
| Original language | English |
|---|---|
| Pages (from-to) | 178-185 |
| Number of pages | 8 |
| Journal | Molecular and Biochemical Parasitology |
| Volume | 181 |
| Issue number | 2 |
| Early online date | 15 Nov 2011 |
| DOIs | |
| Publication status | Published - Feb 2012 |
| Externally published | Yes |
Keywords
- Antifolate
- Cyclohydrolase
- Dehydrogenase
- Drug target
- Leishmania
- Trypanosoma